INTRODUCTION:

The development of drug-resistant drugs in oral administration is currently one of the most intriguing issues facing researchers in the pharmaceutical industry. In structures that contain soluble chemicals, solubility is a limiting factor in the absorption process.¹ There are a variety of solutions available, but no excipient or method of operation is flexible enough to dissolve a large number of chemical components. Several active candidates can be discarded during development due to their poor melting and the presence of bioavailability.²

Solubility:

When a larger amount of solid is brought into contact with liquid, molecules of the latter are pulled out from its surface till equilibrium is established between the molecules which are leaving the solid and those returning to it. The resulting solution is said to be saturated at the temperature of the experiment, and the extent to which a solute dissolve is referred to as its solubility.³ IUPAC defines solubility in terms of the proportion of substance to solvent.

Units of concentration include molarity, molality, mass per volume, mole ratio, mole fraction, and other units. The extent of solubility of various substances varies from nearly inaudible quantities to comparatively massive quantities, but for any given solute, the solubility has a constant value at a given constant temperature. Once the purity of the drug sample is often assured, the solubility value obtained in week acid and week base is often assumed to be intrinsic solubility (C0), i.e., the basic solubility of at two temperatures, the solubility should be ideal. Set the temperature to 40 °C to ensure physical and chemical stability. At 40°C, water has its highest density, resulting in the lowest aqueous solubility.370C-To support evaluation of biopharmaceuticals⁴.

Expressing Solubility and Concentration^5,3

Solubility is commonly stated as quantity per quantity, percentage, parts, molarity, molality, mole fraction, mill equivalents, and normal solutions, among other concentrations. This is also expressed in terms of the number of parts of solvent required to dissolve one part of solute, as described in the United States Pharmacopeia: USP and BP Solubility Criteria.

Table 1: Expression for approximate

Descriptive term	Part of solvent required per part of solute
Very soluble	Less than 1
Freely soluble	From 1 to 10
Soluble	From 10 to 30
Sparingly soluble	From 30 to 100
Slightly soluble	From 100 to 1000
Very slightly soluble	From 1000 to 10,000
Practically insoluble	10 ,000 and over

Need of Solubility⁶:

A variety of variables can affect the absorption of drugs in the GI tract, with poor water solubility and cell membrane penetration contribute significantly. If an active substance is taken orally, it must be dissolved in the stomach and/or intestinal fluid before passing through the GIT membrane and reaching the circulatory system. The degree of solubility and solubility of water-soluble drugs are two areas of pharmacological research that focus on improving the oral availability of bioavailability of active ingredients. BCS is a scientific system for classifying drugs based on their solubility in water and intestinal access. and in IV drugs, increased solubility increases bioavailability⁶

The list of the World Health Organization (WHO) Essential Medicines Model is provided by the BCS (Biopharmaceutics Classification System) section based on publicly available data. Only 61 of the 130 drugs provided by the WHO can be properly classified.

· 84% of these drugs are classified as category I (very soluble, highly absorbed),

· 17% is classified as grade II (not very soluble, very absorbent).

· Class III (very soluble, inaccessible) makes up 39% of the total

· 10% to fourth grade (not very soluble and accessible).⁷

BCS classification:⁸

Class I: High Resolve Drugs in the classroom I have a high level of absorption and a high level of solubility. Because the melting point of Class I compounds designed as fast-release products usually exceeds abortion, 100% absorption can be predicted if at least 85% of the product dissolves in 30 minutes in vitro pH,; in vivo bioequivalence data are not required to confirm product comparisons., diltiazem, verapamil, and propranolol.

Class II Low Solubility, High Permeability:

Class II Drugs in phase II have a high absorption rate but a low dispersion rate. In addition to the very high doses, in vivo drug dosage is a measure of the absorption rate. Because the bioavailability of these products is expected to be limited by melting point, a link between in vivo bioavailability and in vitro termination rate can be seen. Phenytoin, Danazol, Ketoconazole, Mefenamic acid, and Nifedinpine are some examples.

Class III- Low Permeability, High Solubility:

The phase that reduces the absorption rate of drugs in this class is accessibility. The level and amount of absorption of drugs varies greatly with these drugs. Because absorption is limited by penetration rate, and because reference testing and formulation do not contain compounds that may affect drug intake or GI delivery time, the discontinuation method compared to that used for Class I items may be appropriate. e.g. Captopril, Cimetidine, Acyclovir, Neomycin B.

Class IV- Lower Permeability, Low Solubility:

These chemicals have low bioavailability because they are usually poorly absorbed by the intestinal lining, and a high degree of variability is expected due to their poor oral availability. These chemicals are not only difficult to disperse, but also have low access to all GI mucosa once dissolved. These drugs are known to be very difficult to combine and can have significant variations between titles and titles.

Class boundaries:

Highly Soluble:

When the maximum dosage of a drug dissolves in 250mL of water with a pH range of 1 to 7.5, it is considered very soluble.

Most Reliable:

The pharmacy is said to be highly potent if the amount of absorption in humans is greater than 90% of the given dose.

Immediate Termination:

The drug product is considered to be instantly soluble if it dissolves more than 85 percent of the drug-treated product in 30 minutes using USP apparatus I or II in 900 ml of bath solutions.

Solubilization⁹:

Intermolecular or inter-ionic bond separation in solute, separation of soluble atoms to provide space for solvent solid, and interaction between solvent and solute or ion molecule are all part of of the process. solubilization. The solubilization process is divided into three stages.

Step 1: Holes opens in the solvent

Step 2: Molecules of the solid breaks away from the bulk

Step 3: The freed solid molecule is integratedinto the hole in the solvent

Factors affecting solubility:

Particle Size:

The solubility of the drug is usually equal to the particle size, the surface area and the volume ratio increase as the particle size decreases. The larger surface area allows for more solvent interaction.

Temperature:

If the solution process absorbs energy, the melting point will increase as the temperature rises, but when the solution process releases energy, the melting point will decrease as the temperature rises. In hot solutions, a few solid solvents do not melt slightly. For example, the dispersion of all gases decreases as the temperature of the solution rises.

Pressure:

Changes in pressure probably do not affect the solubility of solids and liquids. However, in gas solutes, an increase in pressure improves melting and a decrease in pressure reduces melting. Soluble and soluble substances At room temperature, only 1 gram of lead (II) chloride can be dissolved in 100 grams of water, and 200 grams of zinc chloride can. The main difference in the melting point between the two compounds is due to their distinct nature.

Molecular size:

When molecules have a molecular weight and the size of a large molecule, the melting of an object is reduced because larger molecules are more difficult to move around atoms in order to settle an object.

Polymorphs:

Polymorph Melting Points Polymorphs have a wide range of melting points. Because solvents are attached to soluble solids, polymorphs will have a wide range of solubility. Due to the small change in free energy, the range of melting differences between different polymorphs is usually only 2-3 folds.

Polarity:

Solubility is affected by the polarity of solute and solvent molecules. Non-polar solute molecules, on the other hand, dissolve in non-tropical solvents, while polar solute molecules dissolve in polar solvents. The polar solute molecule has two endings: positive and negative. The positive effects of solvent atoms will attract negative endings of solute molecules if the solvent molecule is equally polarized. The dipole-dipole interaction is a form of intermolecular energy. Other forces are known as the London dispersion forces, in which the positive atomic nuclei of the solute atom attract the negative electrons of the atomic solvent. This allows the non-polar solvent to bind to solute molecules and dissolve them.

Techniques to Improve Solubility^10,11,12

Body modification, chemical modification of chemical substances, and other processes are all examples of melting point improvement techniques.

Physical Modifications:

· Particle size reduction:

· Micronization

· Nanosuspension

· Sonocrystalisation

· Supercritical fluid process

· Modification of the crystal habit:

· Drug dispersion in carriers

· Complexation

· Physical Mixture

· Co-grinding

· Kneading method

· Neutralization

· Spray-Drying Method

· Microwave Irradiation Method

· Coprecipitate method

· Lyophilization/Freezedryg

Chemical Modifications:

· Change in pH

· Use of buffer

· Derivatization

Miscellaneous Methods

· Co-crystallisation

· Co-solvency

· Hydrotrophy

· Solubilizing agent

· Selective adsorption on insoluble carrier

· Solvent deposition

· Using soluble prodrug

· Functional polymer technology

· Precipitation porous

· Micropartical technology

· Nanotechnology approaches

Methods for Solbility Enhancement:

Solid Dipersation:

Strong dispersions were first introduced in 1961 by Sekiguchi and Obi to improve the dissolution and absorption of oral soluble drugs. melting can also lead to eutectic (non-molecular level mixing) or solid solution (molecular level mixing) products.¹³

Types of Strong Spreads:

The use of a solid frame in the molding results in a decrease in particle size, improved moisture, and increased dispersion of the drug, all of which improve the melting point significantly. Possible alternatives to this large increase in dispersion rate are the following:

· Slightly altering glittering drugs into amorphous forms or altering their shiny shape

· Production of solid solutions.

· Structure

· Powerful mixing of drugs with hydrophilic materials

· Reduction of agglomeration and aggregation

· In the distribution layer, this improves the moisture and solubility of the drug by the carrier.⁷

Distribution of Meditation:

Solid scattering divided into 3 groups;

1. Strong first-generation dispersal:

The formation of eutectic compounds or cell dispersions improved the rate of drug release, which also increased the availability of soluble solvents in solid first-generation dispersal. The solid crystalline structure is negative because it does not release the drug immediately. Example: Urea, sugar, and organic acids are examples of crystal carriers.¹⁴

2. Second Generation Solid Dispersion:

In the second generation, we use amorphous carriers that increase the release of drugs, such as povidone (PVP), polyethyleneglycols (PEG), and polymethacrylates, which are fully synthetic polymers. Cellulose extracts, such as hydroxypropyl methylcellulose (HPMC), ethylcellulose, or hydroxypropyl cellulose, or starch derivates, such as cyclodextrins, make up most of the product-based polymers.¹⁵

3. Third generation dispersal:

For the third generation, we use a carrier with extra work and effort structures. Surfactants reduce the regeneration of the drug and thus increase its solubility. The Poloxamer 408, Tween 80, and Gelucire 44/14 are examples of hard-working network companies.¹⁶

Advantages of solid dispersion:

1. Reducing particle size: the use of different carriers in solid dispersion reduces the particle size of the drug, improving solubility and bioavailability.

2. Improve Particle Moisture: Solid dispersion improves particle wetting.

3. Increase porosity: Solid dispersions consisting of straight polymers produce larger, more porous particles than those with reticular polymers, resulting in faster melting.

4. Improved dissolving, which improves melting and ultimately bioavailability.

Solid dispersion malformations:

1. Moisture content causes instability.

2. Difficulty in incorporation in the formulation of volume form.

Formulation Methods of Soliddispersion¹³

1. Solvent evaporation method:

In this process, both the drug and the carrier are dissolved in the same solvent, which later evaporates under a vacuum to produce a solid solution. Tachibechi and Nakumara were the first to combine a solvent (-carotene) and a solvent (PVP) in one solvent, and then evaporate the solvent under a vacuum to produce a solid dispersion. Solvents such as ethanol, chloroform, or a combination of ethanol and dichloromethane are commonly used. Cosolvant can be used in some cases as complete removal of the drug by the carrier may require a large amount of solvents and heat. The basic advantage of the solvent method is that, due to the very low temperatures required to evaporate organic solvents, temperature fluctuations of chemicals or carriers can be avoided. Disadvantages of the solvent method include the cost, environmental impact, and difficulty finding common and removable solvents, as well as the difficulty of completely eliminating liquid solvents and duplicating crystal form.

2. Combination/melting method:

The actual mixture of wood and water-soluble carrier was heated directly until it melted. Crushing, rubbing, and filtering the resulting solid mass improves drug solubility and the bioavailability of the drug. The limitation of the approach is that many drugs may be dispersed at high temperatures.

3. Hot melt extrusion: [HME]

HME is the process of drilling new material (extrudate) through a hole or die under controlled conditions, including temperature, mixing, feed rate, and pressure. In contrast to simple extrusion, HME does not require granulation solvents because the polymer, drug, and excipient compounds are well integrated into the dissolving state. The thermal bond is a molten polymer.

Advantages of HME

1. Improve the solubility and bioavailability of solvents.

2. Strategies without the use of solvents or water:

3. Low cost process characterized by short production time, few processing steps, and continuous process.

4. Dispersion of fine particles occurs in a similar manner.

5. Stability under various conditions of pH and humidity.

6. Because they do not swell and do not melt water, they are safe for human consumption.

Disadvantages:

1. This rule does not apply to heat-sensitive materials.

2. There is a limited amount of polymer available.

3. This method requires a lot of energy.

HMEs are a complex combination of active drugs and auxiliary substances. Other polymers most commonly used in HME are polyethylene glycol, polyethylene oxide, hydroxypropyl cellulose, hydroxypropylmethyl cellulose, poly (dimethylamino ethyl methacrylate-co-methacrylate ester), and ammonio.

Figure 1: Phase diagram of super critical fluid study.¹⁸

Sonocrystallization:

Melt sonocrystallization is a relatively recent method of particle engineering. This method achieves light through ultrasonic radiation frequency of 20 to 100 kHz. Ultrasound power was previously used in the pharmaceutical industry to increase the solubility of soluble drugs. The first stage of crystallization nucleation is influenced by the ultrasound system. Ultrasonication causes particle scattering and deagglomeration. Ultrasonic cavitation is a remarkable phenomenon.

Ultrasound power causes repetitive compression and increased sonocrysatllization. The bubble forms, swells, and crashes after many cycles. The force created by the bubble wrap. Particle cracking was caused by this force. This results in repeated and predictable crystal light. When ultrasonic waves are used to break crystals, the following results are obtained:

a. Nucleation at the lowest level of supersaturation, in which gloss overcomes the tendency of the re-mixing solution to dissolve in solution.

b. The range of metastable sinuses decreases.

c. Distribution of particle size is small.

d. Decrease in the amount of cooling required to achieve gloss.

e. Crystallization is very repetitive and predictable.

f. Polymorphism Management.

Figure3: Process of Sonocrystallization.

Complexation¹³:

A complexation is the formation of a non-binding business with well-defined stochiometry by the combination of two or more molecules. London’s energy, hydrogen bonding, and hydrophobic interactions are all involved in the integration process.

There are two different types of complexes:

1. Stacking complexes:

It is caused by the interaction of the non-white area of the tree with a complex agent, which prevents the non-cooling surface from contact with water, reducing the overall capacity of the system. Packing may be the same or different, but the end result is always a clear solution.

2. Installed properties:

It is made by placing an idle molecule (or a nonpolar part of a molecule) in the hole of another molecule (or group of molecules). Because there is no power between them, non-bond structures are sometimes known as bond-free systems. Cyclodextrins are a type of cyclic oligosaccharide produced by the breakdown of enzymatic starch. Six, seven, and eight units D - (+) -glucopyranose form three main cyclodextrins, ß, and -CD. Cyclodextrins are hydrophilic on the outside and hydrophobic on the inside. Problems usually use cyclodextrine and its derivatives. They form a combination with the drug, improving drug solubility and the availability of bioavailability.

The most commonly used R-cyclodextrin derivatives in pharmaceuticals are those with improved water solubility (e.g. hydroxypropyl-R-cyclodextrin, HP-R-CD). Complexity is caused by the following forces:

1. The cavity's high-energy water is kept out.

2. The occurrence of ring strain, especially in the case of -CD.

3. Van Der Wal’s interactions,

4. Hydrogen and hydrophobic bindings.

Solid inclusion complexes can be prepared by using following methods:

1. Kneading method:

This method involves immersing CDs in small amounts of water or hydroalcoholic solutions and converting them into adhesives. The medicine is then mixed with the dough and mixed for a set amount of time. After that, the battered dough is dried and sorted.

2. Co-precipitation:

In this process, the right amount of medicine is added to the CD solution. The mixture was kept under magnetic resonance imaging by carefully monitored procedures. The facility is protected from direct sunlight. To prevent the loss of structural water from the inclusion complex, the produced precipitate is vacuum filtered and dried at room temperature. This method can be used in industry.

3. Physical blending method:

This is a straightforward trituration procedure. The CDs and medication are thoroughly mixed together in a mortar and then passed through an appropriate sieve to achieve the correct particle size in the final product.

4. Neutralization method:

In this process, inclusion compounds are precipitated using the neutralisation technique. Dissolve the medication in alkaline solutions such as sodium or ammonium hydroxide and combine it with an aqueous CD solution. It is possible to achieve a clear solution. This solution is neutralised with hydrochloric acid solution under agitation until it reaches the equivalence point. A white precipitate is forming at this time. This solution is then filtered and dried.

5. Milling/Co-grinding technique:

This procedure is used to create solid binary inclusion compounds of the medication and CD. In this procedure, the drug and CDs are thoroughly combined before being placed in an oscillating mill and ground for the appropriate amount of time. The binary complex is also prepared in a ball mill.

6. Lyophilisation/Freeze drying technique:

Lyophilization/drying is an effective procedure for obtaining powdered, amorphous powder with a high level of drug interaction with CD. This method works best with thermo-labile materials. In this method, the solvent system from the solution is removed by initial cooling and subsequent drying of the solution, which contains both drugs and CD at low pressure.

7. Microwave irradiation method:

This approach uses a microwave oven to perform a microwave irradiation reaction between the medication and the complexing agent. In a round-bottom flask, the medication and CD are dissolved in a certain molar ratio in a mixture of water and organic solvent in a specified proportion. In a microwave oven, the mixture is reacted to for one to two minutes at 60 degrees Celsius. After the reaction is complete, a sufficient amount of solvent mixture is added to the reaction reaction mentioned above to eliminate any remaining free radicals and CDs. The rain was then separated using a Whatman filter paper and dried for 48 hours in a vacuum oven at 40°C. Microwave irradiation is a unique technology for preparing an industrial scale as there are advantages to faster response time and higher product yield.

8. Supercritical antisolvent method:

In this process, carbon dioxide is used as an anti-solvent solute but as an organic solvent solvent. Because of its low critical temperature and pressure, carbon dioxide is an important choice for heat-labile therapies. This method is important in increasing the bioavailability of chemically active chemicals. Due to its large mass transfer and solvent capacity, carbon dioxide has emerged as a new compound. The drug and CD are first dissolved in the appropriate solvent, and then the nozzle is used to transport the solution to the pressure vessel under critical conditions (i.e., spraying on supercritical fluid anti-solvent). anti-solvent, anti-solvent dissolves rapidly in that liquid solvent as carrier anti-solvent dissipates in anti-solvent. The mixture becomes supersaturated when a highly concentrated expanded liquid has a lower solubility than pure solvent, resulting in a better solute and the solvent being removed with a higher liquid flow.

CO-Solvancy Method:

Cosolvents, also known as solvent blending, are used to promote the solubility of a soluble substance in water by adding a soluble water solution where the drug is well soluble. Severely soluble drugs can be given orally or by the manufacturer in the form of co-solvent. Mixing the solvent is another name for this process. Groups that supply Hydrogen bond and / or receptors, as well as small hydrocarbon regions, are found in many chemical solvents. Their hydrophilic hydrogen bonding groups provide water diversity, while their hydrophobic hydrocarbon properties disrupt the hydrogen bonding water network, reducing intermolecular water attraction. Cosolvents increase solubility by preventing the compulsive fluid from leaking non-polar, hydrophobic molecules by disrupting their cohesion.

Advantage:

1. High concentrations of highly soluble substances can be dissolved, compared to previous solvent methods.

2. Compared with soluble solvents alone, solvents can increase the solubility of soluble molecules thousands of times. Water solubility is bad for weak and nonpolar electrolytes, but can be improved by changing the polarity of the solvent.

3. It is an easy and quick way to combine and make.

Grnulation:

Patel Rajanikant and colleagues developed a floating granules in 2010 to improve drug solubility and bioavailability by increasing the average duration of stay in the stomach. The mixing process was used to make floating ibuprofen granules. Ibuprofen dissolves slowly but has a high concentration in the stomach. It passes through the stomach and into the small intestine, where it melts but cannot pass through the membranes.

To solve this problem, it was logically decided to create a formation that would last in the stomach for longer than 2 hours because the drug did not completely dissolve within 2 hours, and this could not be done using a floating dose form. They prepare floating granules using Gelucire 44/14 polymers (fast-release volume polymer) and Gelucire 43/01 (sustain release granule), which resulted in 100% drug release in 150 minutes per region. of the abdomen, where it remained at 99.9%. unionized and incorporated into system rotation.

Spherical Agglomeration:

It is a method of particle engineering called spherical agglomeration. It is a three-step process that combines crystallization, agglomeration, and spheronization to turn fine crystals into circular particles. This approach is important in improving the drainage of flow structures and the degree of elimination of soluble drugs. The amount and method of circulating liquid addition, as well as the temperature and vibration speed, should all be developed in this process to form a circular crystal.

Advantages:

1. The medication molecule's micromeritics properties improve.

2. This approach aids in the improvement of the drug's wettability and flow properties.

3. This approach can also be used to disguise the taste of some drugs.

Disadvantages:

1. Selecting solvents is time-consuming in this procedure.

2. To keep a process parameter constant.

Nano Suspension:

Nanosuspension is an important means of improving the solubility of soluble drugs. Medical nanosuspension is a mixture of highly dispersed drug particles suspended in a liquid vehicle for treatment of the mouth, head, parents, and lungs. Solid particles in nanosuspensions have a dispersing size of 200 to 600nm particles. The size of particals was reduced in nanosuspension, which improves surface area, consequently, the dissolution rate and melting, which improves bioavailability. Nanosuspension is a solid colloidal compound composed entirely of pure chemical particles. Compounds with high P content, high melting point, and high volumes dissolved in water (but dissolved in oil) are suitable nanosuspension candidates. Insoluble drugs in both soluble and organic solvents can benefit from nanosuspension technology.

Benefits of nanosuspension:

1. This method of action increases the solubility of the drug and the presence of bioavailability, which leads to faster initiation of action.

2. Nanosuspensions can be used to improve the bioavailability of drugs with a high value of log P.

3. It is possible to reduce the dose.

Methods of preparing nanosuspension: ¹⁹

There are two main ways to prepare nanosuspension

1. Low technology at the top

2. High technology down

In the process of ascending, the tree dissolves in a soluble substance, which is then introduced into the insoluble state, causing the fine particles of the tree to decompose. Drugs with rainwater that do not melt well in wet and dry areas are not suitable for rain. When it comes to down-to-earth strategies, there are many options:

A. High pressure homogenization (dissocubes/nanopure)

a. Combined precipitation and homogenization (Nanoedege)

b. Nanojet technology.

B. Milling techniques

a. Media milling (Nanocrystals)

b. Dry co-grinding.

C. Emulsion solvent diffusion method.

D. Super critical fluid method.

CONCLUSION:

For oral bioavailability, formulation, development of multiple dosage forms of different medications, and quantitative analysis, solubility is the most essential physical feature of a drug. The rate-determining stage for oral absorption of poorly water-soluble medicines is drug dissolution, which can have an impact on in vivo absorption. Many drugs' bioavailability is affected as a result of their solubility problems, necessitating solubility enhancement. To address the solubility issue, numerous industrially practical solubility enhancement technologies are being developed today. By employing the newer methods described above, it is possible to increase the solubility of weakly water-soluble medicines.

REFERENCES:

1. Sheetal Z Godse1, Mohini S Patil1, Swapnil M Kothavade1, R. B. Saudagar2; Phytochemical and Pharmacological Profile of lanatacamara L.: An Overview; J. Adv. Pharm. Edu. & Res. 2013: 3(4): 403-414.

2. Pharmaceutical Composite of Poorly Water Soluble Drugs And Polymers. Int. Application published under the patent cooperation Treaty (PCT), WIPO.Int. Publication no. (WO2012/085197A1): 1-58.

3. Remington: The Science and Practice of Pharmacy, Vol.2, 21st Edition. Published by Wolter Kluwer Health (India):196,211-229, 2005.

4. Alton’s Pharmaceutics: The design and manufacturing of medicines, Churchill Livingstone Elsvier.3rd edition: 322-538.

5. Wahab A, Khan A, Khan G.M. Preparation And Evaluation Of Solid Dispersions Of Ibuprofen Using Glucosamine HCL As A Carrier. British Journal of Pharmaceutical Research, 2013;3(4): 722-733.

6. Sandip Kumar, Pritam Singh, Various techniques for solubility enhancement: An overview, The Pharma Innovation Journal 2016; 5(1): 23-28

7. Mankar S. D, Rachh P. R, Solubility enhancement of poor water soluble drugs by solid dispersion: a review, Journal of Drug Delivery and Therapeutics. 2018; 8(5):44-49

8. Reddy B., Karunakar A, Biopharmaceutics classification system: a regulatory approach, Dissolution Technologies 2011; 31-37.

9. Chaudhary A, Nagaich U, Gulati N, Sharma V, Khosa R, Enhancement of Solubilization and Bioavailability Of Poorly Soluble Drugs By Physical And Chemical Modifications: A recent review, Journal of Advanced Pharmacy Education and Research 2012; 2:1: 32-67.

10. Arunachalam A, Karthikeyan M, Kishore K, Pottabathula H.P, Sethuraman S, Hutosh kumar S.A. Solid Dispersions. Current Pharma Research, 2010,1(1).

11. Kapadiya N, Indrjeet S, Mehta K, Karwani G, Shrubo J.S. Hydrotropy: A Promising Tool for Solubility Enhancement. Int. J Drug Discovery and Resarch, 2011;3(2):26-33.

12. Jain P, Goel A, Sharma S, Parmar M. Solubility enhancement techniques with special emphasis on hydrotrophy. International Journal of Pharma Professional’s Research, 2010.

13. S. V. Kadam, D. M. Shinkar, R. B. Saudagar, Review on Solubility Enhancement Techniques, International Journal of Pharmacy and Biological Sciences (e-ISSN: 2230-7605)

14. Sharma D, Soni M, Kumar S, Gupta G.D, Solubility Enhancement -Eminent Role in Poorly Soluble Drugs. Research Journal of Pharmacy and Technology, 2: 220-224, (2009)

15. Vasconcelos T. F, Sarmento B, Costa P, Solid dispersion as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discovery Today, 12: 1068-1075, (2007)

16. Kamalakkannan V, Puratchikody A, Masilamani K, Senthilnathan B, Solubility enhancement of poorly soluble drugs by solid dispersion technique–A review. Journal of Pharmacy Research, 3: 2314-2321, (2010)

17. Subramaniam B, Rajewski R. A, Snavely K, Pharmaceutical processing with supercritical carbon dioxide. Journal of Pharmaceutical Science, 86: 885-890, (1997)

18. Phillips E.M, Stella V.J, Rapid expansion from supercritical solutions: application to pharmaceutical processes. International Journal of Pharmaceutics, 94: 1-10, (1993)

19. Soni S, Patel T, Thakar B, Dr. Pandya V, Dr. Bharadia P, Nanosuspension: An Approach to Enhance Solubility of Drugs. IJPI’s J. Pharmaceutics and Cosmetology, 2(9): 49-63, (2012).

20. S.D.Mankar. Dr.Punit R. Rachh ,2018 solubility enhancement of poor water soluble drugs by solid dispersion- A review, Journal of drug delivery & Therapeutics. 2018,8(5)44-49

Received on 20.01.2022 Modified on 07.03.2022

Asian J. Res. Pharm. Sci. 2022; 12(3):231-238.

DOI: 10.52711/2231-5659.2022.00041